Abstract:aims: Our aim is to demonstrate that honokiol is an effective therapeutic candidate for human ATCs which exerts proliferation inhibition via elevation of ROS and suppresses tumor metastasis. Background: Honokiol is a natural polyphenolic compound extracted from Magnolia officinali, which is commonly used material in Chinese herbal medicine, has a variety of biological functions, including anti-tumor, anti-oxidant, anti-inflammation, anti-microbial and anti-allergy. Although honokiol has numerous beneficial effects on human diseases, the underlying mechanisms of tumor metastasis are still unclear. Previously, we reported that honokiol suppresses thyroid cancer cell proliferation with cytotoxicity through cell cycle arrest, apoptosis, and dysregulation of intracellular hemostasis. Herein, we hypothesized that the antioxidant effect of honokiol might play a critical role in thyroid cancer cell proliferation and migration. background: Honokiol is a natural polyphenolic compound extracted from Magnolia officinali, which is commonly used material in Chinese herbal medicine, has a variety of biological functions, including anti-tumor, anti-oxidant, anti-inflammation, anti-microbial and anti-allergy. Although honokiol has numerous beneficial effects on human diseases, the underlying mechanisms of tumor metastasis are still unclear. Previously, we reported that honokiol suppresses thyroid cancer cell proliferation with cytotoxicity through cell cycle arrest, apoptosis, and dysregulation of intracellular hemostasis. Methods: The cell viability assays, cellular reactive oxygen species (ROS) activity, cell migration, and immunoblotting were performed after cells were treated with honokiol. objective: Herein, we hypothesized that the anti-oxidant effect of honokiol might play a critical role in thyroid cancer cell proliferation and migration. Results: Based on this hypothesis, we first demonstrated that honokiol suppresses cell proliferation in two human anaplastic thyroid carcinoma (ATC) cell lines, KMH-2 and ASH-3, within a dosage- and time-dependent manner by cell counting kit-8 (CCK-8) assay. Next, we examined that honokiol induced ROS activation and could be suppressed by pre-treated with an antioxidant agent, N-acetyl-l-cysteine (NAC). Furthermore, the honokiol suppressed cell proliferation can be rescued by pre-treated with NAC. Finally, we demonstrated that honokiol inhibited ATC cell migration by modulating epithelial-mesenchymal transition (EMT)-related markers by Western blotting. method: The cell viability assays, cellular reactive oxygen species (ROS) activity, cell migration, and immunoblotting were performed after cells treating with honokiol. Conclusion: Taken together, we provided the potential mechanism for treating ATC cells with honokiol, which significantly suppresses tumor proliferation and inhibits tumor metastasis in vitro through reactive oxygen species (ROS) induction. result: Based on this hypothesis, we first demonstrated that honokiol suppresses cell proliferation in two human anaplastic thyroid carcinoma (ATC) cell lines, KMH-2 and ASH-3, within a dosage- and time-dependent manner by cell counting kit-8 (CCK-8) assay. Next, we examined that honokiol induced ROS activation and could be suppressed by pre-treated with an anti-oxidant agent, N-acetyl-l-cysteine (NAC). Furthermore, the honokiol suppressed cell proliferation can be rescued by pre-treated with NAC. Finally, we demonstrated that honokiol inhibited ATC cell migration by modulating epithelial-mesenchymal transition (EMT)-related markers by Western blotting. conclusion: Taken together, we provided the potential mechanism for treating ATC cells with honokiol, which significantly suppresses tumor proliferation and inhibits tumor metastasis in vitro through reactive oxygen species (ROS) induction. other: The epithelial-mesenchymal transition (EMT) mechanism is critical and results in honokiol-inhibited ATC cell migration.

Impact of honokiol on growth and radiosensitivity in nasopharyngeal carcinoma cells

Honokiol Induces Apoptosis and Autophagy Via the ROS/ERK1/2 Signaling Pathway in Human Osteosarcoma Cells in Vitro and in Vivo.

PUB045 Anti-Tumor Effect of Honokiol in Lung Squamous Cell Carcinoma

[Hinokiol Regulates the Cell Cycle and Apoptosis of Nasopharyngeal Carcinoma CNE1 Cells Via Hippo-YAP Signaling Pathway].

Effects of honokiol on proliferation and apoptosis of human cervical carcinoma cell line Hela in vitro

Honokiol Augments the Anti-Cancer Effects of Oxaliplatin in Colon Cancer Cells

Honokiol induces apoptosis of lung squamous cell carcinoma by targeting FGF2-FGFR1 autocrine loop.

Honokiol: a Promising Small Molecular Weight Natural Agent for the Growth Inhibition of Oral Squamous Cell Carcinoma Cells.

Liposomal Honokiol, a Potent Anti-Angiogenesis Agent, in Combination with Radiotherapy Produces a Synergistic Antitumor Efficacy Without Increasing Toxicity.

Effect of Polyphyllin I on Radiosensitivity in Nasopharyngeal Carcinoma Cell Line CNE-2 in Vitro

Mechanism of Apoptotic Induction on T24 Cells by Honokiol and Its Synergistic Anticancer Effect in Combination with Hydroxycamptothecin

Effect of PolyphyllinⅠ on Radiosensitivity in Nasopharyngeal Carcinoma Cell Line CNE-2 in Vitro

Honokiol Suppresses Cell Proliferation and Tumor Migration through ROS in Human Anaplastic Thyroid Cancer Cells

Honokiol: a potent chemotherapy candidate for human colorectal carcinoma.

Honokiol Induces Paraptosis And Apoptosis And Exhibits Schedule-Dependent Synergy In Combination With Imatinib In Human Leukemia Cells

Inhibiting Effect of Mitomycin C on Human Nasopharyngeal Carcinoma Cell Line HNE2、HNE2/lmp1 and Its Mechanism

Effects of Curcumin Analogue B50 on Proliferation and Apoptosis of Homologous Nasopharyngeal Carcinoma Cells with Different Radioresistance

Effect of Apoptosis Induced by Mitoxantrone on Human Nasopharyngeal Carcinoma Cell Line CNE-2

Reactive oxygen species production and Bax/Bcl-2 regulation in honokiol-induced apoptosis in human hepatocellular carcinoma SMMC-7721 cells.

Honokiol, a natural therapeutic candidate, induces apoptosis and inhibits angiogenesis of ovarian tumor cells.

Honokiol Triggers Receptor-Interacting Protein Kinase 3-Mediated Cell Death of Neuroblastoma Cells by Upregulating Reactive Oxygen Species